Profilo
Martin Kristofferson is currently Chief Operating & Supply Chain Officer at EQL Pharma AB since 2026.
Formerly, Mr. Kristofferson was Sourcing Director at BioGaia AB and Chief Marketing Officer at LEO Pharma AB. Education includes a graduate degree from the University of Linköping.
Posizioni attive di Martin Kristofferson
| Società | Posizione | Inizio |
|---|---|---|
| EQL PHARMA AB | Direttore operativo | 17/08/2022 |
Precedenti posizioni note di Martin Kristofferson
| Società | Posizione | Fine |
|---|---|---|
LEO Pharma AB
LEO Pharma AB LEO Pharma AB is an independent, Swedish research-driven pharmaceutical company specializing in dermatology, with a history spanning over 100 years from its origins in Copenhagen. The company is based in Malmö, Sweden. The company employs approximately 5,200 people worldwide and serves 92 million patients across 130 countries. LEO Pharma is majority-owned by the independent LEO Foundation, with Nordic Capital holding a minority stake. Its Nordic hub operates in Sweden, with about 25 employees focused on sales, marketing, medical affairs, and supply. The company’s product portfolio includes dermatological and thrombotic treatments. | Vendite & Marketing | - |
| BIOGAIA AB | Corporate Officer/Principal | - |
Formazione di Martin Kristofferson
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
BioGaia AB
BioGaia AB Pharmaceuticals: OtherHealth Technology Develops health care products such as foods with healthy additives and provides pharmaceutical research services | Health Technology |
University of Linköping
University of Linköping Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EQL Pharma AB
EQL Pharma AB Pharmaceuticals: GenericHealth Technology Manufactures and distributes generic and specialty pharmaceutical products | Health Technology |
LEO Pharma AB
LEO Pharma AB LEO Pharma AB is an independent, Swedish research-driven pharmaceutical company specializing in dermatology, with a history spanning over 100 years from its origins in Copenhagen. The company is based in Malmö, Sweden. The company employs approximately 5,200 people worldwide and serves 92 million patients across 130 countries. LEO Pharma is majority-owned by the independent LEO Foundation, with Nordic Capital holding a minority stake. Its Nordic hub operates in Sweden, with about 25 employees focused on sales, marketing, medical affairs, and supply. The company’s product portfolio includes dermatological and thrombotic treatments. |
















